These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6166718)

  • 21. Mouse alloantibodies capable of blocking cytotoxic T cell function. III. Studies of the mechanism of blocking of CML by anti-Lyt-2 antibodies.
    Shinohara N; Taniguchi M; Kojima M
    J Immunol; 1981 Oct; 127(4):1575-8. PubMed ID: 6974198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
    Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
    J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry.
    Ceredig R; Glasebrook AL; MacDonald HR
    J Exp Med; 1982 Feb; 155(2):358-79. PubMed ID: 6120202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat T lymphocyte antigens comparable with mouse Lyt-1 and Lyt-2,3 antigenic systems: characterization by monoclonal antibodies.
    Matsuura A; Ishii Y; Yuasa H; Narita H; Kon S; Takami T; Kikuchi K
    J Immunol; 1984 Jan; 132(1):316-22. PubMed ID: 6606669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biosynthesis and maturation of the Lyt-2/3 molecular complex in mouse thymocytes.
    Lüscher B; Rousseaux-Schmid M; Naim HY; MacDonald HR; Bron C
    J Immunol; 1985 Sep; 135(3):1937-44. PubMed ID: 3874909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactive and H-2-restricted Lyt 23 cytotoxic T lymphocytes derive from a common pool of antecedent Lyt 123 precursors.
    Hardt C; Pfizenmaier K; Röllinghoff M; Klein J; Wagner H
    J Exp Med; 1980 Nov; 152(5):1413-8. PubMed ID: 6968813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 2 induces both, growth and maturation of lectin reactive Lyt-2+ but not Lyt-2-precursor cells and regulates the cytolytic potential of effector cells.
    Hochgeschwender U; Diamantstein T; Prester M; Nerz G; Simon MM
    Immunobiology; 1986 Apr; 171(3):274-301. PubMed ID: 3086217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal anti-Lyt-2.2 antibody blocks lectin-dependent cellular cytotoxicity of H-2-negative target cells.
    Hünig T
    J Exp Med; 1984 Feb; 159(2):551-8. PubMed ID: 6363597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization.
    MacDonald HR; Glasebrook AL; Cerottini JC
    J Exp Med; 1982 Dec; 156(6):1711-22. PubMed ID: 6983559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of TL+ thymocytes with different Lyt phenotypes.
    Kisielow P; Dráber P; Wysocka M
    Eur J Immunol; 1979 Dec; 9(12):1023-5. PubMed ID: 317705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.
    Kruisbeek AM; Mond JJ; Fowlkes BJ; Carmen JA; Bridges S; Longo DL
    J Exp Med; 1985 May; 161(5):1029-47. PubMed ID: 3921649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse alloantibodies capable of blocking cytotoxic T cell function. II. Further study on the relationship between the blocking antibodies and the products of the Lyt-2 locus.
    Shinohara N; Hämmerling U; Sachs DH
    Eur J Immunol; 1980 Aug; 10(8):589-94. PubMed ID: 6967414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiotypic determinants on T-cell subpopulations.
    Binz H; Frischknecht H; Shen FW; Wigzell H
    J Exp Med; 1979 Apr; 149(4):910-22. PubMed ID: 85685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing.
    Davignon D; Martz E; Reynolds T; Kürzinger K; Springer TA
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4535-9. PubMed ID: 7027264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector T lymphocytes in lymphocytic choriomeningitis virus-infected mice. Cytolytic activity of Lyt-23 spleen cells in vitro does not correlate with elimination of infectious virus from spleens.
    Varho M; Lehmann Grube F; Simon MM
    J Exp Med; 1981 Apr; 153(4):992-7. PubMed ID: 6972995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposome facilitated xenogeneic approach for studying human colon cancer immunity: carrier and adjuvant effect of liposomes.
    Raphael L; Tom BH
    Clin Exp Immunol; 1984 Jan; 55(1):1-13. PubMed ID: 6607141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cultured Lyt-2- L3T4- T lymphocytes from normal thymus or lpr mice express a broad spectrum of cytolytic activity.
    Budd RC; Cerottini JC; MacDonald HR
    J Immunol; 1986 Dec; 137(12):3734-41. PubMed ID: 3491147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterologous cross-linking of Lyt-2 (CD8) to the alpha beta-T cell receptor is more effective in T cell activation than homologous alpha beta-T cell receptor cross-linking.
    Boyce NW; Jönsson JI; Emmrich F; Eichmann K
    J Immunol; 1988 Nov; 141(9):2882-8. PubMed ID: 3262671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.